Whose Physique is It Anyway?
Does not appeal to you, does it?
Would you like to turn over handle of your wellness and viability – possibly your extremely longevity – to an understaffed, underfunded government bureaucracy?
Doesn’t appeal to you, does it?
The FDA (U.S. Food & Drug Administration), which if you feel about it for a little whilst, has extraordinary energy over your individual nicely-becoming – may possibly obtain even a lot more dominance more than your destiny. The battle for planet domination of your physique will occur this fall in the august chambers of the U.S. Supreme Court.
The foundation of the legal fight is the Vermont Supreme Court selection in Levine v. Wyeth.
Diana Levine, a professional musician, was treated, in April 2000, for a severe migraine headache and nausea. Staff at the Vermont Health Center injected her with Phenergan, a nausea medication. They utilized her arm to administer the injection and the outcome was really disastrous: she lost her appropriate arm below the elbow, and left the hospital an amputee.
Levine sued Wyeth, which sells Phenergan, on the basis that the warning label on Phenergan – although it complied with FDA specifications – was inadequate. Levine won a jury trial and was awarded about $6.8 million.
Wyeth appealed the choice since it wants to hide behind the FDA. The case went to the Vermont Supreme Court which ruled against Wyeth, saying, in essence, the drug manufacturer had a duty beneath state law to strengthen the warning label on the drug, regardless of the FDA’s confusing, and sometime conflicting, regulations on when, or if, warning labels should be revised.
The Politics of Pre-Emption
At the heart of the upcoming U.S. Supreme Court battle is the idea of pre-emption: that federal law pre-empts the correct of victims such as Diana Levine to sue for the damages inflicted upon them in state courts.
The [supposed] logic is this: if the FDA has approved the drug, or healthcare device, and the label, then drug makers need to have only to comply with the FDA’s needs to be granted sweeping immunity against personal injury law suits filed in state court for damages based for failure to warn. Or as the New York Instances stated the drug organizations are hunting for “a legal shield” against becoming held accountable.
Why is it that significant corporations, and a lot of of their Republican supporters, are constantly speaking about accountability and responsibility, until it comes to them?
The complete factor is scary.
Right here is an agency – the FDA – which is understaffed and not keeping up with technology – faced with the possibility of assuming even far more handle over our quite getting. USA Today published a story – citing an independent panel evaluation of the FDA – which revealed that the agency has about the very same size staff as 15 years ago. According to the article, As an alternative of becoming proactive, the agency (FDA) is often in “fire-fighting” mode.
If the U.S. Supreme Court rules in favor of Wyeth, upholding the pre-emption rule, it takes away one particular of the significant legal treatments the typical U.S. citizen has when events such as Diana Levine’s nightmare happens.
And yes, politics, notably the Bush administration, is solidly evident. The Bush Administration has moved stealthily to stop state widespread law claims.
In January 2006, the FDA adopted new regulations, the ultimate goal was to torpedo efforts to let personal injury claims to be heard by state court juries.
The FDA said “it is the professional federal public agency charged by Congress with insuring that drugs are safe and successful and that their labeling adequately informs users of the risks and advantages of the item and is truthful and not misleading.” Translation: “if we say it won’t kill you, it will not kill you.”
And because when is the FDA in the job of insuring something? These are the very same people who can even inspect imported food to make certain it is secure.
Take all the extremely technical legal argument out of this and there is nonetheless the aspect of human error, of an understaffed agency monitoring an exponentially developing number of pharmaceutical products, and the potential for this agency to slam the door in a citizen’s face ought to a medical catastrophe happen.
In May possibly, the Congressional Committee on Oversight and Government Reform held hearings on the pre-emption situation. Chairman, Rep. Henry Waxman, said in his statement, that if the pharmaceutical managers, the FDA and the Bush Administration have their way in court, “…a single of the most strong incentives for safety, the threat of liability, would vanish.”
Whose physique is it anyway? Yours, or the FDA’s?
Onward.
Richard Alexander
For more, please go to: attorney marketing
Related Posts
Tags
Share This
Recent Comments